Moderna ($MRNA) steps into Thursday’s analyst day with more pressure than momentum. The stock is down more than 40% this year ...

Moderna has been rebuked by regulators after offering children cash to test the Covid vaccine. The pharmaceutical company was ordered to pay £14,000 after it emerged that a representative had sent a ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...

mRNA-4359 has advanced into the Phase 2 portion of the ongoing Phase 1/2 trial CAMBRIDGE, MA / ACCESS Newswire / October 12, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that clinical, safety ...

New capabilities strengthen U.S. production, completing Moderna’s domestic end-to-end mRNA manufacturing network More than $140 million investment will create hundreds of highly skilled ...

Moderna revealed Wednesday that its flu vaccine using mRNA technology has offered promising results as the flu season begins to ramp up. Moderna announced that its seasonal flu vaccine “demonstrated ...

Forbes contributors publish independent expert analyses and insights. Randy Bean is a noted Senior Advisor, Author, Speaker, Founder, & CEO. While the application of data and AI holds the potential to ...

Vaccine makers Pfizer and Moderna are trying to get out ahead of some of the new coronavirus variants that are causing concern around the world. Although there's no evidence people immunized with ...

Moderna and Merck’s new mRNA vaccine reduces the chance of relapse or death of skin cancer by half when paired with Merck’s immunotherapy drug Keytruda, new data shows, marking a step forward in the ...

Fall season is also flu season, and it's a time when people are accustomed to receiving their annual shots. This year it will also serve as the first big test of demand for COVID shots. COVID vaccine ...

ZURICH (Reuters) - Roche is partnering with Moderna to include a COVID-19 antibody test in the mRNA specialist's ongoing vaccine trials, the Swiss drugmaker said on Wednesday, potentially ...

All three companies are working on updated vaccines for COVID. A new variant, XBB.1.5, led to a spike in COVID cases in China earlier this year. Despite that news, demand for COVID vaccines may not be ...